Dorottya Nagy-Szakal

Dr. Nagy-Szakal has 15+ years of experience in translational medicine and microbiology, extensively focused on clinical metagenomics (urine, joint and challenging infections) using NGS-based technologies. She led cutting-edge clinical trials on fecal microbiota transplantation, gut-brain axis, multi-omics studies and the COVID-19 pandemic response with the ultimate goal of improving diagnostics and developing novel therapies. Her work represents 30+ articles (JAMA, Nature Communications, Scientific Reports, Cell and MBio) and book chapters as a leader in the clinical metagenomic space. At Biotia, she drives strategic communications with the FDA, CDC, NYS DOH, enterprise medical centers and is responsible for the clinical operations, medical affairs and clinical/R&D laboratory operations.

Dr. Nagy-Szakal is a research assistant professor at SUNY Downstate Health Sciences University and previous completed postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University. She earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary.